The Hamas terror organization on Monday morning announced that US-Israeli hostage Edan Alexander will be released on Monday, but did not disclose the time and location. The Trump administration is exploring the possibility that, following Alexander’s release, US special envoy Steve Witkoff will fly him and his parents to Qatar to meet President Trump, Ynet reported. However, such a scenario is dependent on Alexander’s condition upon his release. A hostage release ceremony will not be held before Alexander is handed over to the Red Cross, a Hamas official told AFP. IDF forces are preparing to secure a safe passage in Gaza for Alexander’s release. A senior Israeli source said: “We’re preparing to receive Edan Alexander sometime today.

The family of Rabbi Sholom Ber Lipskar zt”l, rov in Bal Harbour, Florida, concluded the shivah mourning period this week.
In the days following his petirah, expressions of grief and support poured in from across Florida and around the globe, as people remembered Rabbi Lipskar’s immense contributions and enduring legacy.
Among the many who came to offer condolences was U.S. Senator Rick Scott, who traveled to Florida immediately after casting a vote in Washington, D.C. He went straight to the shivah house, where he spent time with Rabbi Lipskar’s widow, Rebbetzin Chani Lipskar, and their family.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds (15 kilograms). That’s according to the study funded by Lilly, which was published Sunday in the New England Journal of Medicine. Both drugs are part of a new class of medications that work by mimicking hormones in the gut and brain that regulate appetite and feelings of fullness. But tirzepatide targets two such hormones, known as GLP-1 and GIP, while semaglutide targets GLP-1 alone, said Dr.

Holocaust survivor Magda Baratz a”h, was niftar at age 96 just days after learning of the petirah of her beloved great-grandson, Master Sergeant Asaf Cafri Hy”d, who fell in battle while defending Israel in Gaza. Baratz, a survivor of both Auschwitz and Bergen-Belsen, was in Germany as the guest of honor at a Holocaust Remembrance Day ceremony marking 80 years since the liberation of the infamous Bergen-Belsen concentration camp, when the tragic news was delivered. Her grandson Hagai, the father of Asaf, had accompanied her on the trip. He received word of his son’s death shortly after their arrival. Asaf, 26, a resident of Beit Hashmonai and a reserve soldier in the IDF’s Armored Corps, was killed by sniper fire from a Hamas terror cell in Beit Hanoun.

During an appearance on this week’s “Fox News Sunday,” Senator Tom Cotton (R-AR) asserted that the Iranian leadership lives in fear of President Donald Trump.
Host Shannon Bream brought up the ongoing negotiations with Iran, currently being led by U.S. Envoy Steve Witkoff, and cited a recent statement he made to Breitbart: “We’ve stated our position the Iranians cannot have a bomb. They have stated back to us that they don’t want one. So we’re going to for the purposes of this discussion take them at their word that that’s actually how they feel. Do you take them at their word?”

People taking the obesity drug Zepbound lost nearly 50% more weight than those using rival Wegovy (Ozempic) in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds.

US hostage envoy Adam Boehler seen escorting Edan Alexander’s mother to Israel ahead of her son’s slated release on Monday.

WASHINGTON (AP) — President Donald Trump is ready to accept a luxur

By Ruthie Blum
Israelis awoke to fake news that, in Winston Churchill’s witty words, “got halfway around the world before the truth had a chance to put its pants on.”
The baloney began with coverage by i24News of an item that appeared in The Jerusalem Post. So much of the Hebrew channel’s morning broadcast was devoted to what it was touting as a huge deal that other outlets picked it up and ran with it.
Ditto for social media, of course.
The trouble is that everything about the bulletin was wrong, starting with an inaccurate attribution of its origin. Indeed, anybody who bothered to check could see that the piece in the JPost was a reprint of a write-up in The Media Line.